Trials / Completed
CompletedNCT03568526
Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer
The Effects of a Sensorimotor Rehabilitation Program on the Upper and Lower Limbs of Persons With Cancer Following Taxane-Based Chemotherapy for Early Stage Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Ohio State University Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This clinical trial studies how well the sensorimotor rehabilitation program works in improving quality of life in patients with early stage breast cancer. A hand and foot sensory improvement program from occupational and physical therapists may improve patients' function in everyday tasks and overall quality of life.
Detailed description
PRIMARY OBJECTIVES: I. To investigate the effects of an innovative, new sensorimotor rehabilitation program on persons with cancer following taxane-based chemotherapy for early stage breast cancer. OUTLINE: Patients attend 1 therapy session to receive education and training in the use of the home program. Patients then complete exercises over 90 minutes per week for 6 weeks.
Conditions
- Peripheral Neuropathy
- Stage I Breast Cancer AJCC v7
- Stage IA Breast Cancer AJCC v7
- Stage IB Breast Cancer AJCC v7
- Stage II Breast Cancer AJCC v6 and v7
- Stage IIA Breast Cancer AJCC v6 and v7
- Stage IIB Breast Cancer AJCC v6 and v7
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Educational Intervention | Attend a therapy session |
| BEHAVIORAL | Exercise Intervention | Complete exercise |
| OTHER | Quality-of-Life Assessment | Ancillary studies |
| OTHER | Questionnaire Administration | Ancillary studies |
| OTHER | Survey Administration | Ancillary studies |
Timeline
- Start date
- 2015-07-02
- Primary completion
- 2018-02-08
- Completion
- 2022-09-14
- First posted
- 2018-06-26
- Last updated
- 2022-10-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03568526. Inclusion in this directory is not an endorsement.